These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 947955)

  • 21. Spontaneous cell-mediated cytotoxicity by human peripheral blood lymphocytes in vitro.
    Nelson DL; Bundy BM; Strober W
    J Immunol; 1977 Oct; 119(4):1401-5. PubMed ID: 894045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
    Nelson DL; Sachs DH; Dickler HB
    J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of mononuclear effector cells in human blood.
    Hersey P; Edwards A; Edwards J
    Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.
    Hunninghake GW; Haynes BF; Parrillo JE; Fauci AS
    Clin Exp Immunol; 1978 Apr; 32(1):186-91. PubMed ID: 668191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
    Fuson EW; Cole AJ; Hubbard RA
    J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the cytotoxic activities of different human lymphoid tissues.
    Durántez A; de Landazuri MO; Silva A; Alvarez J; Kreisler M
    J Clin Lab Immunol; 1979 Apr; 2(1):59-65. PubMed ID: 95808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between effector lymphocytes in natural and antibody-mediated cytotoxicity.
    Benczur M; Györffy G; Garam T; Varga M; Medgyesi G; Sándor M; Petranyi GG
    Immunobiology; 1979 Sep; 156(3):320-9. PubMed ID: 540970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.
    Phillips JH; Lanier LL
    J Immunol; 1986 Mar; 136(5):1579-85. PubMed ID: 2419407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals.
    Edwards DL; Avis FP
    J Immunol; 1979 Oct; 123(4):1887-93. PubMed ID: 479605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent cell-mediated cytolysis (ADCC): analyses and projections.
    Lovchik JC; Hong R
    Prog Allergy; 1977; 22():1-44. PubMed ID: 325576
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
    Ericson SG; Benoit NE; Mills LE; Fanger MW
    Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
    Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz Martínez J
    Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.